Literature DB >> 15994269

Sleep x 9: an approach to treatment of obstructive sleep apnoea/hypopnoea syndrome including upper airway surgery.

C F Ryan1.   

Abstract

This article provides an overview of the management of the obstructive sleep apnoea/hypopnoea syndrome (OSAHS). Where possible, recommendations are based on a review of the relevant literature. With the exception of nasal continuous positive airway pressure, which is considered in greater detail elsewhere in the series, and certain oral appliances, the efficacy of many proposed treatments for OSAHS is not supported by data from randomised controlled clinical trials. To a considerable extent, treatment recommendations are based on data from uncontrolled studies, case series, consensus guidelines, practice parameters, and other less rigorous forms of evidence.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15994269      PMCID: PMC1747442          DOI: 10.1136/thx.2004.036442

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  109 in total

1.  Laser CO2 for snoring. Preliminary results.

Authors:  Y V Kamami
Journal:  Acta Otorhinolaryngol Belg       Date:  1990

2.  Surgical maxillofacial treatment of obstructive sleep apnea.

Authors:  W Hochban; R Conradt; U Brandenburg; J Heitmann; J H Peter
Journal:  Plast Reconstr Surg       Date:  1997-03       Impact factor: 4.730

Review 3.  Obstructive sleep apnea syndrome: a complex disorder of the upper airway.

Authors:  A E Sher
Journal:  Otolaryngol Clin North Am       Date:  1990-08       Impact factor: 3.346

4.  Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea.

Authors:  A I Pack; J E Black; J R Schwartz; J K Matheson
Journal:  Am J Respir Crit Care Med       Date:  2001-11-01       Impact factor: 21.405

5.  Effect of nasal-valve dilation on obstructive sleep apnea.

Authors:  B Schönhofer; K A Franklin; H Brünig; H Wehde; D Köhler
Journal:  Chest       Date:  2000-09       Impact factor: 9.410

6.  Cognitive impairment in patients with obstructive sleep apnea and associated hypoxemia.

Authors:  L J Findley; J T Barth; D C Powers; S C Wilhoit; D G Boyd; P M Suratt
Journal:  Chest       Date:  1986-11       Impact factor: 9.410

7.  Effect of flurazepam on sleep-disordered breathing and nocturnal oxygen desaturation in asymptomatic subjects.

Authors:  F R Dolly; A J Block
Journal:  Am J Med       Date:  1982-08       Impact factor: 4.965

8.  Characterization of postoperative edema following laser-assisted uvulopalatoplasty using MRI and polysomnography: implications for the outpatient treatment of obstructive sleep apnea syndrome.

Authors:  D J Terris; A A Clerk; A M Norbash; R J Troell
Journal:  Laryngoscope       Date:  1996-02       Impact factor: 3.325

9.  Effect of short-term sleep loss on breathing.

Authors:  K R Cooper; B A Phillips
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1982-10

10.  A randomized trial of temperature-controlled radiofrequency, continuous positive airway pressure, and placebo for obstructive sleep apnea syndrome.

Authors:  B Tucker Woodson; David L Steward; Edward M Weaver; Shahrokh Javaheri
Journal:  Otolaryngol Head Neck Surg       Date:  2003-06       Impact factor: 5.591

View more
  2 in total

1.  Compliance to continuous positive airway pressure therapy in a group of Portuguese patients with obstructive sleep apnea syndrome.

Authors:  Claudia Alves; José Manuel Pinto Chaves Caminha; Antonio Martins da Silva; Denisa Mendonça
Journal:  Sleep Breath       Date:  2011-06-21       Impact factor: 2.816

Review 2.  Obstructive sleep apnea, hypertension and cardiovascular diseases.

Authors:  C Gonzaga; A Bertolami; M Bertolami; C Amodeo; D Calhoun
Journal:  J Hum Hypertens       Date:  2015-03-12       Impact factor: 3.012

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.